- Home
- SKLZ vs BRNS Comparison
SKLZ vs BRNS Comparison
Compare SKLZ & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKLZ | BRNS |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 55.9M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SKLZ | BRNS |
|---|---|---|
| Price | $3.30 | $0.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $4.00 |
| AVG Volume (30 Days) | ★ 72.1K | 59.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.98 | 18.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $92,865,000.00 | $14,969,000.00 |
| Revenue This Year | $13.33 | N/A |
| Revenue Next Year | $12.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $3.10 | $0.56 |
| 52 Week High | $9.11 | $2.91 |
Technical Indicators
Market Signals| Indicator | SKLZ | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 41.48 | 38.07 |
| Support Level | $3.10 | $0.56 |
| Resistance Level | $4.08 | $0.76 |
| Average True Range (ATR) | 0.25 | 0.07 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 23.53 | 12.11 |
Price Performance
Historical ComparisonAbout SKLZ Skillz Inc.
Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. The company's reportable business segments are: the Skillz segment and the Aarki segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is an artificial intelligence company that delivers advertising solutions. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The majority of its revenue is generated from the Skillz segment. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.